Arvantis Pharmaceuticals

Arvantis Pharmaceuticals is a Munich-based specialty pharmaceutical company that focuses on the development and commercialization of value-added medicines and high-quality generics. As part of the Arvantis Group, the company leverages a lean, entrepreneurial approach to identify off-patent molecules that can be improved through innovative reformulations or new delivery methods. Their business model centers on enhancing patient outcomes and treatment adherence by optimizing established therapies. Arvantis Pharmaceuticals operates primarily in the European market, targeting therapeutic areas where significant unmet needs remain despite the availability of existing treatments.